Non-Surgical Device for Treatment of Middle Ear Effusion

治疗中耳积液的非手术装置

基本信息

  • 批准号:
    6406750
  • 负责人:
  • 金额:
    $ 48.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-15 至 2003-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant) The purpose of this study is to test the efficacy of a portable, automated, modified Politzer device for the nonsurgical management of middle-ear effusion in children (4-11 years of age). The objectives of this study are to determine whether the change in average air-bone gap and tympanometric peak pressure from the final pre-test to the post-test is greater for the experimental subjects who receive treatment with the device as compared with the control subjects. Subjects with middle-ear effusion will be randomly assigned to the experimental (n=59) and control groups (n=59). Each experimental subject will receive twice-daily treatment (administered by the guardian) with a portable, automated, modified Politzer apparatus over a period of 7 weeks. Post-testing (audiologic and otolaryngologic evaluations) will occur three weeks after the period encompassed by the treatment. The significance of this study will have far-reaching benefit in terms of a reduction of the need for surgical treatment for middle-ear efThsion . with resultant avoidance of possible adverse sequellae, and substantial reduction of cost of management from approximately $2,000 for surgical treatment to approximately $10 for nonsurgical management. PROPOSED COMMERCIAL APPLICATIONS: If the clinical trial proves to be successful, there will be national and international interest. Although the custom-made device costs $325 including product liability, when commercially produced, it will cost about $5.00.
描述(由申请人提供)本研究的目的是测试 便携式自动改良Politzer装置在非手术治疗中的疗效 4~11岁儿童中耳积液的处理这个 这项研究的目的是确定平均水平的变化 气骨间隙和鼓室峰值压力从最终的预试到 接受治疗的实验受试者的后测更大 将该装置与对照组进行比较。中耳受试者 渗出液将被随机分配到试验组(n=59)和对照组 组(n=59)。每个实验对象将接受每天两次的治疗 (由《卫报》管理)配有便携式、自动、改装的Politzer 仪器超过7周的时间。后测试(听力学和 耳鼻喉科评估)将在三周后进行 被治疗所包围。这项研究的意义将具有 减少手术治疗需求方面的深远好处 对于中耳的EfThsion。从而避免了可能的不利影响 后遗症,并大幅降低管理成本 手术治疗2,000美元,非手术治疗约10美元。 建议的商业应用: 如果临床试验被证明是成功的,将会有国家和国际利益。尽管这款定制设备的价格为325美元(含产品责任),但在商业化生产时,它的成本约为5美元。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANIEL S ARICK其他文献

DANIEL S ARICK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANIEL S ARICK', 18)}}的其他基金

DEVICE FOR NONSURGICAL MANAGEMENT OF OTITIS MEDIA
中耳炎非手术治疗设备
  • 批准号:
    2720234
  • 财政年份:
    1998
  • 资助金额:
    $ 48.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了